Most cases of blood clots occurred within two weeks of the person receiving their first dose, and most of the cases reported in Europe have been in women under 60.
Survivor of rare blood clot after AstraZeneca COVID-19 vaccine recalls ordeal
Most cases of blood clots occurred within two weeks of the person receiving their first dose, and most of the cases reported in Europe have been in women under 60.